Rexulti 0.25 MG tablet 30S

Ended Awarded

Contract number
SPE2DB23FJT62
Awardee
Awarding agency
Obligated
$5,173

Award facts

Contract value 100% obligated
$5,173.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $5,173 to Amerisourcebergen Drug Corporation for 0.25 mg REXULTI tablets. Under this order, Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 15, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Pharmaceutical Prime Vendor contract to support the medical readiness of U.S. armed forces worldwide. No subcontractors or set-aside designations were identified in the award information.

Quick answers

Who was awarded contract SPE2DB23FJT62?

SPE2DB23FJT62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2023.

How much is contract SPE2DB23FJT62 worth?

The government has obligated $5,173 on SPE2DB23FJT62.

Is contract SPE2DB23FJT62 an order under another contract?

Yes. SPE2DB23FJT62 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.

Was contract SPE2DB23FJT62 competed?

The extent of competition for SPE2DB23FJT62 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award